Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... and therefore were approved to reduce the number of blood transfusions required during chemotherapy; however, concerns about the risks of venous thromboembolism (the disease that includes ...
2009 NOV 25 ... those who underwent resection of the liver lesions compared with those who received only chemotherapy and radiotherapy. A total of 742 patients with stage IV Wilms tumor were enrolled on ...
2009 NOV 25 ... Treatment, Cancer, Oncology, Antitumor Activity, Anticancer Therapy, Drug Therapy, Chemotherapy, Pharmaceuticals, Molecular Pharmaceutics. This article was prepared by ...
2009 NOV 23 ... metachromasia were found in the peripheral blood and on bone marrow aspiration smears. Chemotherapy with cytosine arabinoside and idarubicin was ineffective and the patient died of ...
2009 NOV 23 ... two small cell lung cancer cases had preceded presentation with acute pancreatitis. Chemotherapy (p = 0.008; hazards ratio = 4.99; 95% confidence interval = 1.51-16.54) and an Eastern ...
2009 NOV 23 ... time, and the latter was associated with antiganglioside antibodies. The mechanism of chemotherapy-induced peripheral neuropathy is still in the process of being elucidated with the use ...
2009 NOV 23 ... States, "Recent clinical trials have demonstrated differential survival benefit from chemotherapy regimens according to non-small cell lung cancer (NSCLC) histology. We investigated ...
2009 NOV 23 ... for prediction of lapatinib sensitivity in bladder cancer,' have been published. "Chemotherapy for metastatic bladder cancer is rarely curative. The recently developed small molecule, ...
2009 NOV 23 ... Breast Cancer finds that significant declines in sales in the hormonal therapy and chemotherapy segments of the market will be offset by a 1.2 percent annual increase in breast cancer ...
2009 NOV 23 ... severe renal damage caused by gemcitabine. On the other hand, fluoropyrimidine-based chemotherapy may have some activity against this tumor, because one of the three patients who ...
2009 NOV 23 ... or insufficient data were excluded All patients received neoadjuvant 5-FU-based chemotherapy and external beam radiation Histologic response was categorized as pCR or not-pCR, which ...
2009 NOV 23 ... "Between 2004 and 2006, all patients with carboplatin reinduction chemotherapy received an intradermal injection of 0.2 mu L of carboplatin and saline as negative ...
2009 NOV 23 ... Cui and colleagues published their study in the Journal of Antimicrobial Chemotherapy (Isolation and characterization of methicillin-resistant Staphylococcus aureus from ...
2009 NOV 23 ... sensitive to genotoxins, and ovarian failure and infertility are major side effects of chemotherapy in young patients with cancer. Here we describe the c-Abl-TAp63 pathway activated by ...
2009 NOV 23 ... the tumor cells as metastases of an occult cervical cancer. Primary platin-based chemotherapy combined with paclitaxel leads to a complete apparative remission. Twelve months later, ...
2009 NOV 23 ... jirovecii pneumonia (PCP). PCP occurred during the fourth, sixth, and seventh cycle of chemotherapy, respectively. Among the patients treated by R-CHOP, 3 of 32 (9%) patients whose ...
2009 NOV 23 ... therefore, the cyclophosphamide, vincristine, and dacarbazine (CVD) combination chemotherapy was initiated. The combination chemotherapy was very ...
2009 NOV 23 ... 30s, McCauley was diagnosed with cancer in 2006. He has undergone surgery and extensive chemotherapy treatments, leaving him confined to a wheelchair and needing to carry oxygen. His family ...
2009 NOV 23 ... "For patients suffering from advanced castration resistant prostate cancer, chemotherapy is the only option at this point that has been shown to prolong survival. There is an ...
2009 NOV 23 ... "Besides conventional surgery, radiation therapy, and chemotherapy, which all tend to have side-effects and damage normal tissues, new medical strategies, ...
